Discontinuation of a concomitantly used cytochrome P450 2D6 inhibitor may possibly bring about a reduce in codeine plasma concentration and a rise in Lively metabolite morphine plasma focus which could boost or lengthen adverse reactions and may result in most likely lethal respiratory depression.When the affected person develops these signs or sym